RCUS ARCUS BIOSCIENCES INC
2026Q1 · CUSIP 03969F109 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
209
Δ holders QoQ
+3
Breadth percentile
Top 50%
Whale holders
114
Δ whales
-1
Inst. holding value
$2.6B
New positions
39
Closed positions
36
Price momentum (1Q)
+21.6%
Put / Call
7/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 7 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q2 | Top 12% | +1.1% | -28.8% |
| 2022Q3 | Top 13% | -29.7% | -36.7% |
| 2022Q2 | Top 7% | +10.0% | -28.4% |
| 2022Q1 | Top 17% | +25.8% | +43.2% |
| 2020Q2 | Top 6% | -8.1% | +35.0% |
| 2020Q1 | Top 4% | -27.5% | -33.4% |
| 2019Q2 | Top 11% | +8.0% | +68.4% |
Options Sentiment
Put holders
7
QoQ: -1
Call holders
6
QoQ: -4
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-3.17
EPS YoY
—
Revenue (TTM)
$0.2B
Revenue YoY
+67.4%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)